Biophytis SA

09/03/2025 | Press release | Distributed by Public on 09/02/2025 23:08

Biophytis obtient l\'autorisation de l\'EMA pour le lancement de son étude clinique de phase 2 dans l’obésité

03 Sep 2025 07:00 CEST

Subscribe

Nom de l'emetteur

BIOPHYTIS

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1355839_Approval_EMA_Biophytis_Phase_2_OBA_Sept_VF.pdf

Source

Biophytis

Fournisseur

Les Echos

Company Name

BIOPHYTIS

ISIN

FR001400OLP5

Symbole

ALBPS

Marché

Euronext Growth

Biophytis SA published this content on September 03, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 03, 2025 at 05:08 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]